Amyloid binding ligands as Alzheimer's disease therapies

Neurobiology of Aging

Volumn 23, Issue 6, 2002, Pages 1039-1042

  Lee, Virginia M Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

A ; Brain amyloidosis; Drug discovery; Neurodegenerative diseases

Indexed keywords

AMYLOID; CONGO RED; THIOFLAVINE; VACCINE;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CELL CULTURE; FIBER; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; BRAIN; HUMANS; LIGANDS; SENILE PLAQUES; STYRENES;

EID: 0036860355     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00121-5     Document Type: Article

References (25)

1. Bard F.et al. Peripherally administered antibodies against amyloid-β peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6:2000;916-919.
2. Bayer T.A.et al. Key Factors in Alzheimer's disease: β-amyloid precursor protein processing, metablosim and intraneuronal transport. Brain Pathol. 11:2000;1-11.
3. Borneman K.D., Staufenbiel M. Transgenic mouse models of Alzheimer's disease. Ann. N.Y. Acad. Sci. 908:2000;260-266.
4. Clark, CM, Trojanowski, JQ, editors. Neurodegenerative Dementias: Clinical Features and Pathological Mechanisms. New York, NY: McGraw-Hill; 2000.
5. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D.R., Price D.L.et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat. Neurosci. 4:2001;233-234.
6. Goldsbury C.S.et al. Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors. J. Struct. Biol. 130:2000;217-231.
7. Findeis M.A.et al. Approaches to discovery and characterization of inhibitors of amyloid-peptide polymerization. Biochem. Biophys. Acta. 1502:2000;76-84.
8. Janus C.et al. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
9. Styren S.D., Hamilton R.L., Styren G.C., Klunk W.W. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J. Histo. Cytochem. 48:2000;1223-1232.
10. Kung M-P, et al. In Vivo Detection of Amyloid Plaques by Radioligands for Aβ40 and Aβ42: Potential Imaging Agents in Alzheimer's Patients, in press.
11. Kung M-P, et al. Novel beta amyloid probes. In: Fillit HM, O'Connell AW, editors. Drug Discovery and Development for Alzheimer's Disease. Berlin: Springer; 2000, p. 50-6.
12. Lansbury P.T. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3342-3344.
13. Liu K., Doms R.W., Lee V.M.-Y. Glu11 Site cleavage and N-terminally truncated Aβ production upon BACE overexpression. Biochemistry. 41:2002;3128-3136.
14. Lorenzo A., Yankner B.A. Veta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12243-12247.
15. Russo C.et al. Presenilin-1 mutations in Alzheimer's disease. Nature. 405:2001;531-532.
16. Schenk D. Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
17. D.J. Selkoe, Biology of β-amyloid precursor protein and the mechanism of Alzheimer's disease. In: Terry, RD, Katzman, R, Bick, KL, Sisodia, SS, editors. Alzheimer's Disease. Philadelphia, PA: Lippincot Williams & Wilkins; 1999, p. 293-310.
18. Skovronsky D.M., Lee V.M.-Y. β-Secretase revealed: starting gate for race to novel Alzheimer therapies. Trends Pharmacol. Sci. 21:2000;161-163.
19. Skovronsky D.M. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 977:2000;609-7614.
20. Soto C., Sigurdsson E.M., Morelli L., Kumar A., Castano E.M., Frangione B. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implication for Alzheimer's therapy. Nat. Med. 4:1998;822-826.
21. J.Q. Trojanowski, V.M.-Y. Lee. Brain degeneration linked to "fatal attractions" of proteins in Alzheimer's disease and related disorders. J. Alzheimer's Dis., in press.
22. Vassar R.et al. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
23. Wilson C.A.et al. Intracellular APP processing and Aβ production in Alzheimer disease. J. Neuropath. Exper. Neurol. 58:1999;787-794.
24. Wolfe M.S.et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:1999;513-517.
25. Zhuang Z.P.et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem. 44:2001;1905-1914.